| 摘要 |
The invention relates to a novel sustained release pharmaceutical formulation adapted for administration by injection containing the compound fulvestrant, more particularly to a formulation adapted for administration by injection containing the compound fulvestrant in solution in a ricinoleate vehicle which additionally comprises at least one alcohol and a non-aqueous ester solvent which is miscible in the ricinoleate vehicle. |
